Solazyme®, the Solazyme logo and other trademarks or service names are trademarks of Solazyme, Inc.
Twinlab Corporation is a leading manufacturer and marketer of high quality, science-based, nutritional supplements, including a complete line of vitamins, minerals, nutraceuticals, herbs and sports nutrition products. Since 1968, the Twinlab brand has manufactured and marketed nutritional supplements in both the vitamin and sports nutrition categories. In addition to its namesake brand, Twinlab Corporation also manufactures and sells other well-known category leaders including the Metabolife® line of diet and energy products; Twinlab Fuel® line of sports supplement products; Alvita® teas, established in 1922 as a single-herb tea line; and Nature’s Herbs®, a complete line of herbals and phytonutrients. Twinlab’s manufacturing facility in American Fork, Utah is a NSF GMP-registered facility. Twinlab also runs an R&D facility in Grand Rapids, Michigan; and has its corporate headquarters in New York, NY. Visit www.twinlab.com for more information.
Forward Looking StatementsThis press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 about Solazyme, including statements that involve risks and uncertainties concerning: commercialization plans for Solazyme’s microalgal food ingredients, market demands, and the performance and health benefits of the microalgal food ingredients. When used in this press release, the words “will”, “expects”, “intends” and other similar expressions and any other statements that are not historical facts are intended to identify those assertions as forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any such statement may be influenced by a variety of factors, many of which are beyond the control of Solazyme, that could cause actual outcomes and results to be materially different from those projected, described, expressed or implied in this press release due to a number of risks and uncertainties. Potential risks and uncertainties include, among others: Solazyme’s limited operating history; its limited history in commercializing products; implementation risk in deploying new technologies and products; and market acceptance of its products. Accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on the results of operations or financial condition of Solazyme. In addition, please refer to the documents that Solazyme, Inc. files with the Securities and Exchange Commission, including its Quarterly Reports on Form 10-Q, as updated from time to time, for a discussion of these and other risks. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this press release. Solazyme is not under any duty to update any of the information in this press release.